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PREGNANCY AND DIABETES-
THE IMPROVING PROGNOSIS
by
A.I. TRAUB, J. M.G. HARLEY, D.A.D. MONTGOMERY and D.R. HADDEN
Royal Maternity Hospital, Belfast
THE continuing fall in perinatal mortality for the general population highlights
those conditions such as diabetes which are still associated with an unacceptably
high incidence of intrauterine and perinatal deaths (Fig. 1). The management in
Belfast of patients with pregnancy complicated by diabetes was originally reviewed
in 1956' at which time the perinatal mortality was approximately 20 per cent, i.e. 1
in 5 pregnancies which progressed beyond 28 weeks gestation, resulted in a dead
baby, a stillbirth or neonatal death within seven days of birth. Subsequently, a
combined metabolic/antenatal clinic was established in the Royal Maternity
Hospital, Belfast, in 1959, and over the following 8 years the perinatal mortality was
reduced to 12 per cent.2
The purpose ofthis paper is to present the most recent results from the combined
clinic over 10 years (1.1.72-31.12.81) and to discuss changes in the management of
the pregnant diabetic which may further reduce the perinatal mortality and
morbidity and, perhaps more importantly, reduce the incidence of fetal
malformations.
PATIENTS AND MANAGEMENT
The patients under review were insulin-dependent diabetics diagnosed before
pregnancy, apart from seven who were diagnosed during pregnancy and confirmed
after delivery: their management followed clearly set out guidelines. At the booking
visit to the clinic, all patients who required stabilization of their diabetes were
admitted to hospital and discharged only when control was satisfactory. The
importanceofcontrol was emphasized and thosenot admitted weregiven instruction
in self-monitoring of capillary blood glucose. In the past this was carried out using
visual assessment of a glucose-oxidase impregnated strip (Dextrostix, Ames). More
recently, patients have been taught to use a portable reflectance meter (Glucometer,
Ames) to read the strips and to check preprandial capillary blood glucose four times
daily. Patients attended every two weeks unless more frequent visits were necessary;
the results of venous plasma glucose levels (and latterly glycosylated haemoglobin)
measured 48 hours previously by arrangement with their local hospital or health
centre were available, as were the records of the patients' home monitoring. All
patients were instructed to make minor adjustments in insulin dosage dependent on
the preprandial plasma glucose result, and the overall trend was monitored at each
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FIG. 1
Perinatal mortality in diabetic pregnancy compared with that of the hospital
population. RoyalMaternity Hospital, Belfast, 1940-1981.
clinic visit. The aim was to maintain the plasma glucose as close as possible to 5
mmol/l at all times. Admission to hospital was arranged if at any time there was
difficulty with diabetic control or any obstetric complication arose, particularly pre-
eclampsia or polyhydramnios.
In the thirty-second week of pregnancy all patients were admitted for closer
supervision of their diabetes and continuous intensive assessment of fetal wellbeing
by clinical examination and ultrasonic scanning every two weeks. In addition,
urinary oestriols and serum HPL were measured and cardiotocography was carried
out twice weekly. As inpatients they were referred to the diabetic eye clinic for
ophthalmoscopic examination to detect possible diabetic retinopathy. After the
thirty-sixth week an x-ray of the abdomen was obtained for further examination of
the gestational age and to help exclude fetal malformation. A week later amnio-
centesis was performed and the patient delivered at 38 weeks if fetal pulmonary
maturity was confirmed by a lecithin-sphingomyelin area ratio (LSAR) of greater
than 2.0. Induction of labour or elective caesarean section was carried out after
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,Vconsideration of many factors. A paediatrician was always present at delivery and
the baby admitted to the nursery for observation for at least 24 hours.
RESULTS
One-hundred-and-sixty-nine insulin-dependent patients were treated, 86 per cent
of whom had booked for confinement in the Royal Maternity Hospital, the remain-
ing 14 per cent being transferred from other centres with complications such as poor
diabetic control, severe pre-eclampsia or premature labour. Fifty-four per cent of
patients resided in the Eastern Health and Social Services Board, the rest being
evenly distributed among the other Health Boards in Northern Ireland.
Of the 169 pregnancies, seven ended as spontaneous abortions, one of which was
at 24 weeks. The 162 which progressed beyond 28 weeks gestation included 4 sets of
twins; therefore the number of babies born was 166. Of these, there were 161 live
births, 5 stillbirths and 2 neonatal deaths; 3 of the 7 perinatal deaths were the result
of congenital heart lesions. The perinatal mortality rate was 4.2 per cent and the
stillbirth rate 3.0 per cent. Two further deaths occurred in the fifth week of life: in
one case, the mother overlay the baby as a result of a hypoglycaemic coma, whilst
another baby died from a congenital heart lesion. Both cases, by definition, are not
'perinatal deaths' but in each the maternal diabetes clearly made a major
contribution. Thus, the total fetal loss in this series, including the 7 abortions, was
16 (10 per cent) (Table I).
TABLE I
Outcome in diabeticpregnancy, Royal Maternity Hospital, Belfast, 1972-1981.
PREGNANCIES ... ... ... ... ... 169
Spontaneous abortion ... ... ... ... 7
Twin pregnancy ... ... ... ... ... 4
INFANTS ... ... ... ... ... ... 166
Live birth ... ... ... ... ... 161
Stillbirth ....... ... ... ... ... 5
Neonatal death ... ... ... ... 2
TOTAL FETAL LOSS ... ... ... ... (16) 10%7o
STILLBIRTH RATE ... ... ... ... 3%
PERINATAL MORTALITY RATE ... ... 4.2%
The incidence of congenital abnormality was 16 per cent (Table II) and many of
these were minor abnormalities such as tongue-tie or hypospadias. There were 11
major abnormalities, of which the most common was a heart defect: such lesions
were responsible for 3 of the 7 perinatal deaths. The CNS abnormality was
anencephaly and this pregnancy was terminated at 17 weeks. The bony abnormality
was sacral agenesis, which although rare, has a well recognized association with
maternal diabetes.3 Only one baby had multiple abnormalities and this accounted
for one of the perinatal deaths attributed to a heart defect.
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Congenitalfetal malformations in diabetic pregnancy, Royal Maternity Hospital,
Belfast.
CVS Heart lesions 8
CNS Anencephaly 1
SKELETAL Sacral agenesis 1
MULTIPLE - Heart, kidney, limbs 1
MINOR ABNORMALITIES, eg Hypospadias 15
TOTAL 26
Malformation rate 15.6%
The most common obstetric problems were pre-eclampsia (30 per cent) and
polyhydramnios (17 per cent). The incidence ofurinary tract infection, anaemia and
monilial vaginitis did not differ significantly from that of the general population.
During the last two years five patients were found to have proliferative retinopathy
which required laser photocoagulation during or immediately following the
pregnancy.4
The mode of delivery was by caesarean section in 52 per cent, there being an
added complication such as pre-eclampsia in half of these cases. The forceps
delivery rate was 20 per cent and is considerably higher than that for the general
population, this figure being largely influenced by the increasing use of epidural
anaesthesia.
DISCUSSION
Perinatal mortalityis the end-point bywhich the quality ofantenatal and perinatal
care is judged. It is defined as the number of stillbirths and deaths occurring in the
first seven days of life per 1,000 live and stillbirths. The introduction of a combined
metabolic/antenatal clinic at the Royal Maternity Hospital, Belfast, has brought
about a considerable improvement in the prognosis for diabetic patients over the last
20 years, during which time the perinatal mortality rate has been reduced from 12
per cent to 4.2 per cent and the stillbirth rate from 19 per cent to 3 per cent. These
results compare favourably with other large centres in the United Kingdom but are
still approximately three times that for the general population.
The incidence offetal malformation has propQrtionately increased and during this
time congenital heart lesions were responsible for approximately half of the
perinatal deaths. There is clear evidence that fetal abnormalities are more common
in pregnancy complicated by insulin-dependent diabetes 5 and that with poor control
in early pregnancy the incidence is further increased.6 Data from Pedersen7
suggested that control at the time of conception may be the most important factor
and this has been confirmed by Fuhrman8 who showed that pre-pregnancy counsell-
ing to achieve blood sugar levels at less than 8 mmol/litre around the time of
conception significantly reduced the incidence of congenital abnormalities. In
Belfast, the need for good pre-conceptional blood sugar control was first suggested
in 19799 and subsequently Montgomery et al introduced an explanatory booklet for
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congenital abnormalities has been noted.
The most significant improvement in achieving good diabetic control prior to and
during pregnancy has been the introduction of capillary blood glucose self-
monitoring by the mother, and this has been made sufficiently accurate in average
hands by the use of a reflectance meter of which there are several makes now
available. Since the introduction of the Glucometer (Ames) in 1979, it has become
our policy to instruct all patients in its use when they are admitted to the antenatal
ward following booking at the antenatal clinic. They are provided with this
instrument while in hospital and for those who cannot afford to buy one, several are
available for loan until confinement. Those unable to obtain an instrument are
advised to use the Dextrostix strips with visual comparison with the scale on the
bottle; this method provides a means of self-monitoring superior to random urine
testing which used to be the routine for many diabetics. Just as good pre-pregnancy
control is considered vital to reduce the incidence ofcongenital abnormalities, good
plasma glucose control throughout pregnancy should reduce the incidence of late
unexpected intra-uterine death. Such deaths may be attributed to acute fetal
metabolic derangement secondary to an episode of rapid fluctuation of maternal
plasma glucose and four occurred in our series despite the presence of normal
placental function tests. It was because of this difficulty in predicting those cases
most at risk from sudden fetal death that patients have been admitted in the past
after 32 weeks gestation to allow optimal control of their blood sugars with, if
necessary, daily adjustment of insulin dosage.
Similarly, the policy of delivering patients at 38 weeks was adopted to reduce the
incidence of sudden intra-uterine death after this period; this gestational age was
selected because the problems of prematurity are remote. However, in diabetic
pregnancy the risk of respiratory distress syndrome is increased and, since the
introduction of the amniotic fluid LSAR, diabetic patients have not been delivered
until this ratio was greater than 2 unless there are other pressing indications. The
false positive rate with this test is known to be increased in diabetes'0 and in the
above series three babies developed respiratory distress syndrome when the LSAR
was greater than 2. To overcome this problem, delivery is now deferred until the
appearance in the liquor of phosphatidyl glycerol."
The caesarean section rate in this series, while lower than previously, is still
unacceptably high at almost 50 per cent; the rate for the general hospital population
being approximately 10 per cent. In many cases the decision to deliver the patient by
caesarean section was influenced by the presence in the uterus of a scar from a
previous delivery by this method. However, the major contributory factor is the aim
to deliver the diabetic patient prematurely at which time the cervix, particularly in
the primigravid patient, is usually unfavourable for induction of labour. In centres
where the uncomplicated diabetic pregnancy is allowed to progress a further two
weeks to term it appears that a greater number of patients go into labour
spontaneously with subsequent reduction in the incidence ofinduction oflabour and
caesarean section. Thus, with good diabetic control and adequate fetal surveillance
such practice may be the only way to significantly reduce the caesarean section rate.
However, as discussed above, it is very difficult to predict accurately fetal death in
utero and one must question whether the increased risk ofintra-uterine death would
outweigh the risk of caesarean section.
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diabetic, the benefits of which are evident from the continuing fall in the perinatal
mortality demonstrated above and were clearly highlighted in the National
Survey of Diabetic Pregnancies 1982 (unpublished data)'2 which showed that those
centres delivering the largest number of diabetic patients produced better results,
despite having to cope with referrals of the more difficult cases. The value of pre-
pregnancy counselling is unquestioned and it is theresponsibility ofall physicians to
undertake such counselling of their female diabetic patients in the reproductive age
group. This provides an opportunity to offer contraceptive advice and should
include counselling regarding the risks tothebabyofpoor blood sugarcontrol atthe
time ofconception. To provide such a service a pre-pregnancy clinic has been set up
in the Royal Maternity Hospital, at which some patients who have been counselled
attend at monthly intervals for assessment and appropriate adjustment of insulin.
Other potential mothers are indentified at their own diabetic clinics and seen there
more frequently. It is not yet possible to insist on attendance at a centralized pre-
pregnancy clinic as is practised in East Germany, but it is very important that the
desirability of good pre-conceptional diabetic control should be known to potential
mothers.
SUMMARY
Over the last 10 years, 169 diabetic pregnancies were managed in the Royal
Maternity Hospital, Belfast. The perinatal mortality was 4.2 per thousand and
represents a considerable improvement over the 10 years reviewed. Congenital fetal
malformations have become proportionately more common and accounted for
almost half of the fetal loss.
The continuing improvement in perinatal mortality has largely been attributed to
the intensive care of the pregnant diabetic by a team consisting of obstetrician,
physician and neonatologist. However, to reduce perinatal mortality and morbidity
it is essential that all ins-lin-dependent diabetic patients in the reproductive years
should be counselled regarding the necessity for preconceptional diabetic control.
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